# Stage121 Post-DD Density Follow-up Review(121단계 손실률 압축 뒤 밀도 후속 검토)

- run(실행): `run121A_stage121_v41_post_dd_density_followup_review_v1`
- source_stage(원천 단계): `120_adapter_research__v41_post_dd_density_expansion_repair`
- source_stage120_closeout_commit(원천 120단계 종료 커밋): `f33c473f286c340d2e9ce34aa8b63bf94e8ebe85`
- source_stage120_latest_commit(원천 120단계 최신 커밋): `d825aab76421e0141aeaba5c53dc80d01c51f5d1`
- external_verification_status(외부 검증 상태): `completed_existing_stage120_mt5_runtime_evidence_reviewed`
- decision(판정): `continue_density_scale_repair_in_stage122`
- boundary(경계): `research_development_only_no_live_readiness_no_runtime_authority_no_operating_promotion_no_operating_reference_no_production_baseline_no_deployment`

## Bounded Question(경계 질문)

Stage120(120단계)의 density gain(밀도 증가)이 PF/net/DD(수익 팩터/순손익/손실률)와 segment KPI(구간 핵심 성과 지표)를 보존했는가?

Effect(효과): Stage121(121단계)은 새 실험을 늘리지 않고 Stage120 근거만 판독해 다음 bounded repair(경계 수리)를 정한다.

## Result Table(결과 표)

| adapter(어댑터) | source(원천) | PF(수익 팩터) | net(순손익) | DD%(손실률) | trades(거래 수) | gain(증가) | 34D gap(34D 차이) | read(판독) |
|---|---|---:|---:|---:|---:|---:|---:|---|
| s120_v41_h3_cd9_session_margin_risk035_lng51 | s118_v41_h3_cd9_session_margin_risk035_lng52 | 1.830000 | 1195.83 | 14.390000 | 174 | 0 | -230 | quality_anchor_preserved_no_density_gain |
| s120_v41_h3_cd8_session_margin_risk035_lng52 | s118_v41_h3_cd8_session_margin_risk035_lng53 | 1.730000 | 1070.61 | 14.750000 | 176 | 0 | -228 | quality_anchor_preserved_no_density_gain |
| s120_v41_h3_cd7_session_margin_risk035_lng53 | s118_v41_h3_cd8_session_margin_risk035_lng53 | 1.740000 | 1074.35 | 14.750000 | 177 | 1 | -227 | tiny_density_gain_preserved_pf_net_dd_but_not_enough |
| s120_v41_h3_cd7_session_margin_risk035_lng52 | s118_v41_h3_cd8_session_margin_risk035_lng53 | 1.740000 | 1074.35 | 14.750000 | 177 | 1 | -227 | tiny_density_gain_preserved_pf_net_dd_but_not_enough |

## Best Read(최선 판독)

- quality_control(품질 대조): `s120_v41_h3_cd9_session_margin_risk035_lng51` PF `1.830000`, net `1195.83`, DD `14.390000`, trades `174`
- density_candidate(밀도 후보): `s120_v41_h3_cd7_session_margin_risk035_lng53` PF `1.740000`, net `1074.35`, DD `14.750000`, trades `177`
- plain_read(쉬운 판독): Stage120은 거래 수를 1개 늘렸지만 34D의 404건에는 아직 227건 부족하다. PF/net(수익 팩터/순손익)은 34D보다 높지만 DD%(손실률)는 34D보다 약 1.84%p 높다.

## Tradeoff Notes(트레이드오프 메모)

- `s120_v41_h3_cd9_session_margin_risk035_lng51`: quality_anchor_preserved_no_density_gain -> keep_as_quality_control_not_density_solution
- `s120_v41_h3_cd8_session_margin_risk035_lng52`: quality_anchor_preserved_no_density_gain -> keep_as_quality_control_not_density_solution
- `s120_v41_h3_cd7_session_margin_risk035_lng53`: tiny_density_gain_preserved_pf_net_dd_but_not_enough -> scale_density_with_new_route_supply_or_reentry_source
- `s120_v41_h3_cd7_session_margin_risk035_lng52`: tiny_density_gain_preserved_pf_net_dd_but_not_enough -> scale_density_with_new_route_supply_or_reentry_source

## Judgment(판정)

- result_subject(판정 대상): Stage120 post-DD density expansion evidence(120단계 손실률 압축 뒤 밀도 확장 근거).
- evidence_available(있는 근거): Stage120 MT5 runtime summaries(MT5 실행환경 요약), segment KPI(구간 핵심 성과 지표), risk/ATR telemetry(위험/ATR 원격측정), gate feature summary(게이트 피처 요약).
- evidence_missing(부족 근거): 34D 수준 trade density(거래 밀도), 34D 수준 DD%(손실률), full equity-shape audit(전체 자본 곡선 형태 감사).
- judgment_label(판정 라벨): `tiny_density_gain_not_sufficient`.
- claim_boundary(주장 경계): `research_development_only_no_live_readiness_no_runtime_authority_no_operating_promotion_no_operating_reference_no_production_baseline_no_deployment`.
- next_condition(다음 조건): Stage122(122단계)에서 거래 수를 실질적으로 늘리되 PF/net/DD와 위험/ATR telemetry(원격측정)를 보존해야 한다.

Forbidden claims(금지 주장): deployment(배포), live readiness(실거래 준비), production baseline(생산 기준선), operating promotion(운영 승격), operating reference(운영 기준), runtime authority(런타임 권위), legacy inheritance(레거시 상속).
